Center for Genetic Engineering and Biotechnology and Medical Research Center, Ain Shams
University, Cairo, Egypt
Pediatric Department, Genetics Unit, Faculty of Medicine, Ain Shams University, Cairo, Egypt
on-alcoholic fatty liver disease (NAFLD) is known as a major cause of chronic liver disease in pediatric population. The disease forms vary from simple steatosis, and non-alcoholic steatohepatitis (NASH), fibrosis to hepatocellular carcinoma (Li et al., 2016; Sookoian and Pirola, 2017) . NAFLD is known as the metabolic syndrome, as its main components are abdominal obesity, insulin resistance, atherogenic dyslipidemia and hypertension (Li et al., 2016; Sun et al., 2016) . Its incidence is 9.6% of children in general and up to 38% of obese children (Manti et al., 2014; Molleston et al., 2014) . Genetics as well as environmental factors effect on NAFLD and its development (Hotta el al., 2010) .
Several gene variants have been identified by genome wide association studies (GWAS) as associated with fatty liver disease. The strongest gene variants associated with fatty liver are the petaninlike phosphate 3 (PNPLA3) and the glucokinase regulatory protein (GCKR) (Marzuillo et al., 2014) . Single nucleotide polymorphism (SNP) rs738409 in PNPLA3 gene is characterized by a mutation for C base to G base, which causes a change in an amino acid from isoleucine (I) to methionine (M) at the position 148 of the obtained protein (1148 M). This protein is associated with elevated hepatocyte fat content (Santoro et al., 2012) . SNP rs1260326 in the GCKR gene is a C to T substitution which leads to change in amino acid proline (Pro) to leucine (L) at the position 446 in the obtained protein (Santoro et al., 2012) . The effective protein of this gene is a regulatory protein that inhibits glucokinase in liver and pancreatic islet cells by binding noncovalently to form an inactive complex with the enzyme (Santoro et al., 2012) .
Although, the association of the PNPLA3 and GCKR genes in the NAFLD around the world has been recognized, few studies on the Egyptian patients were reported. Therefore, this study aimed to investigate the role of PNPLA3 rs738409 and the GCKR rs1260326 SNPs in the development of NAFLD in a sample of obese Egyptian children. (Table 1) .
N PATIENTS AND METHODS

This
DNA extraction and genotyping
Genomic DNA was extracted from whole blood using spin column method of Gene-JETTM Genomic DNA purification kit (Fermentas Life Sciences, Finland).
The eluted DNA was stored at -20C until further use.
Genotyping for the rs738409 SNP in the PNPLA3 gene and the rs1260326 polymorphisms in the GCKR gene was performed by PCR based RFLP analysis. The following primers were used: rs738409 SNP: F: 5'-TGG GCC TGA AGT CCG AGG GT-3' and R: 5'-CCG ACA CCA GTG CCC TGC AG-3' (Alyavi et al., 2014) . For the rs1260326 SNP: F: 5'-TGC AGA CTA TAG TGG AGC CG-3' and R: 5'-CAT CAC ATG GCC ACT GCT TT-3' (Santoro et al., 2012) . A total of 20 ng of genomic DNA was amplified by polymerase chain reaction (PCR) containing 0.2 mM of forward primer and 0.2 mM of reverse primer, 10x PCR buffer, 1.5 mM MgCl 2 , 200 mM dNTPs, and 1 unit of Taq DNA Polymerase (Promega, UK) in a 25 ml volume. Biometra PCR (Germany) (Table 2) .
Statistical analysis
Statistical analyses were performed using statistical package of social sciences (SPSS) software Program for IBM SPSS statistics (Version 21.0). Data were expressed as median and percentages for quantitative nonparametric measures in addition to number and percentage for categorized qualitative variables. Quantitative data were presented as mean ± SD for normally distributed data. Chi-square (X 2 ) test was used to compare between groups. P value < 0.05 was considered as significant and P< 0.01 as highly significant.
RESULTS AND DISCUSSION
NAFLD is a common public health problem. GCRR and PNPLA3 genes are known to be associated with the NFLD worldwide. To our knowledge, in Egypt, only one studies showed the effect of genetic polymorphism in the promoter of microsomal triglyceride transfer protein (MTP) in NAFLD (El-Koofy et al., 2011) .
But No previous study illustrated the effect of GCKR and PNPLA3 variants on NAFLD. Increasing body mass index (BMI) and obesity are known as risk factor for NAFLD (Aragones et al., 2016) .
In order to achieve our goal, 80 patients diagnosed with NAFLD and 80 healthy children were recruited to study the association between GCKR rs1260326 and PNPLA3 rs738409 polymorphisms with NAFLD Egyptian obese patients as well as to understand the role of these polymorphisms in the development of NAFLD. Forty-six (57.5%) out of the patients group were males and 34 (42.5%) were females. The patients' ages ranged from 5 to 13 years with mean of (8.5 years ± 4.4). There were no significant differences in age and gender between NAFLD patients and their control. NAFLD patients divided into two groups; NAFL (group 1) which include patients with simple steosis, and NASH (group 2) which includes patients suffered from hepatomegaly and elevated liver enzyme. There were highly significant differences between the two groups in weight, height, BMI, hip and waist circumferences, cholesterol, TG, LDL, ALT and AST (Table  1) .
Genotyping for GCKR rs1260326 and PNPLA3 rs738409 polymorphisms was carried out using PCR based RFLP. Figure (1) shows the differences between the three genotypes of both polymorphisms visualized on polyacrylamide gel.
Regarding the PNPLA3 rs738409 polymorphisms, there were 17 individuals (21.25%) homozygous for the risk allele (GG). Whereas, 39 individuals (48.75%) were heterozygous (GC). Moreover, 24 individuals (30%) were homozygous with the wild allele (CC). There were significant differences between the tree genotypes in patients compared to their control.
The risk allele (G) frequency was 45.6% in patients and 36.3% in control, with highly significant differences between them ( Table 3) .
As for the GCKR rs1260326 polymorphisms, among all the patients, 15 individuals (18.75%) were homozygous for the risk allele (TT) with no significant difference between them and their control.
Whereas, 48 individuals (60%) were heterozygous (TC). Moreover, 17 individuals (21.25%) were homozygous with the wild allele (CC). There were highly significant differences between the heterozygous and wild homozygous (CC) between patients and their control. The risk allele (T) frequency was 48.8% in the patients and 33.1% in the control, with highly significant differences between them (Table 4 ).
Many studies showed that the allele frequency of PNPLA3 and GCKR varied in different ethnic groups (Palmer et al., 2013; Lin et al., 2014; Zhang et al., 2015) . The frequency of the risk allele (G) in PNPLA3 rs738409 polymorphism was 0.266 in Caucasian, 0.170 in African American, 0.417 in the Hispanics (Santoro et al., 2012) , 0.448 in Asians (Lin et al., 2014) . While the risk allele frequency (T) in the GCKR rs1260326 variant was 0.446 in Caucasian, 0.129 in African American and 0.355 in Hispanics (Santoro et al., 2012) .
In the present study, Table (5) illustrates a comparison between NAFL (group 1) and NASH (group 2) in genotypes and allele frequency for PNPLA3 rs738409 polymorphism. It is evident that there were seven individuals (17.5%) and 10 individuals (25%) in NAFL and NASH group, respectively, who carried the homozygous genotype (GG). There were significant differences between the three genotypes in the two groups. Moreover, there were significant differences between the two groups in the frequency of the risk allele (G), this mean that the PNPLA3 rs738409 polymorphism may play a role in the progressive of NAAFLD in the Egyptian obese children On the other hand, group 1 (NAFL) and group 2 (NASH) in the GCKR rs1260326 polymorphisms revealed that there were five individuals (12.5%) and 11 individuals (27.5%) in NAFL and NASH group, respectively, who carry the homozygous genotype (TT). Moreover, the risk allele frequencies (T) were 41.3% and 57.5% in group 1 and group 2, respectively (Table 6 ). The results indicated that (T) allele is more strongly associated with NASH. Therefore, it is expected that this polymorphism may have an important role in the development of NAFLD in the Egyptian obese children.
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Studies on obese children who suffer develop NAFLD indicated that genetic and/or environmental factor may influence the susceptibility of the patient (Lin et al., 2014) . Hotta et al. (2010) reported that (G) allele of rs738409 may be involved in the development of NALD in Japanese patients. Moreover, Santoro et al. (2012) suggested that both of PNPLA3 and GCKR act to confer susceptibility to NAFLD. It is noteworthy; that Aragones et al. (2016) illustrated that PNPLA3 could be related to the progression of simple steatosis in obese women. Our results showed partial agreement with these findings.
Final conclusion, our findings suggest that GCKR rs1260326 and PNPLA3 rs738409 with obesity may play an important role in the development of NAFLD in obese Egyptian children, with later seem to have greater impact in this respect.
SUMMARY
Non-Alcoholic fatty liver disease (NAFLD) is known as a common public health problem worldwide. Genetic variant as well as environmental factor interact to develop NAFLD. The allele frequency of PNPLA3 and GCKR variant varied in different ethnic groups. Our study aimed to recognize the association of the PNPLA3 rs738409 and GCKR rs1260326 with the occurrence and progression of NAFLD in obese Egyptian children. 
